Bharat Biocon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bharat biocon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bharat Biocon Today - Breaking & Trending Today

Covid Vaccination: Are Indians being made guinea pigs?


Efficacy report pending, yet government greenlights use of indigenously developed Covaxin
Sabrangindia16 Jan 2021
Even as India kickstarts its nationwide Covid vaccination campaign, a new controversy has erupted over the approval to use Bharat Biotech’s indigenously developed Covaxin, whose efficacy data is still awaited.
Concerns are being raised about granting emergency use authorisation to Covaxin, an indigenously developed vaccine manufactured by Bharat Biocon, even though the third phase of its trial isn’t completed and its efficacy data is not yet available. In fact, the authorization was granted “in clinical trial mode”, which raises even more questions.
There are at present two vaccines that are being offered; Covishield developed by a team from Oxford University in association with pharma major Astra Zeneca, and Covaxin, an indigenously developed Covid vaccine manufactured by Bharat Biocon in association with the Indian Council ....

New Delhi , Narendra Modi , Krishna Ella , Malini Aisola , Bharat Biocon , India Drug Action Network , Ministry Of Health , Indian Council Of Medical Research , Ministry Of Health Mo , India Peoples Science Network , Member Health , Oxford University , Bharat Biotech , Indian Council , Medical Research , Third Phase , All India Drug Action Network , All India Peoples Science Network , Central Government , State Governments , India Today , Family Welfare , Minister Narendra Modi , புதியது டெல்ஹி , நரேந்திர மோடி , கிருஷ்ணா எல்லா ,